Abstract:To the Editor: The success of deep brain stimulation generally depends on a good grasp of surgical indications, precise implantation of electrodes, and the optimal adjustment of programmable parameters (1). Programming settings are modified through contact selection, pulse width, frequency, and amplitude, to achieve optimal control of clinical symptoms with minimal stimulation parameters. Hence, programming is a crucial aspect of DBS, which directly influences its therapeutic efficacy (2). DBS patients are typically required to undergo three stages of programming: intraoperative, initial postoperative, and follow-up postoperative. Intraoperative programming is intended to test the physical connectivity (impedance) of the DBS system and the clinical efficacy of DBS, thereby providing indirect evidence of accurate electrode placement (3,4). The goal of initial postoperative programming is to identify the minimal stimulation parameters needed to achieve optimal control of clinical symptoms. The purpose of followup postoperative programming is to perform appropriate adjustments to stimulation parameters according to changes in the patient’s condition, including disease progression and suboptimal symptom control due to medication adjustments. Different programming requirements exist at different programming stages. Intraoperative programming time should be minimized to reduce total operation time, while the surgical procedure should be adapted to minimize risk of infection caused by programming. For initial postoperative programming, the time needed to ascertain optimum stimulation parameters should also be minimized, and reasonable arrangement of numerous patients’ programming schedules must be organized. Finally, follow-up postoperative programming should maximize patient convenience by reducing the time and financial cost of travelling between the patient’s home and the hospital. There are a number of inadequacies in conventional programming methods. First, the programming probe must come into close contact with the implantable pulse generator (IPG) and test stimulator to complete programming. However, the probe is not sterile during intraoperative programming and must therefore be wrapped in a sterile plastic bag before it can be attached to the IPG. Furthermore, when measuring the physical connectivity of the DBS product, the surgeon must pause the surgery and make room for the attachment between the programming probe and IPG. During initial postoperative programming, only the parameters of one patient can be ascertained. In addition, the same frequency is typically used in the left and right brain for dual channel IPG. During follow-up postoperative programming, the patient must repeatedly travel between their home and the hospital, leading to increased time and expense. An ideal solution to the outlined issues lies in wireless and remote programming technology. With this technology, the need for an additional probe is eliminated, as is the need for close contact, thus significantly reducing the risk of infection. Furthermore, all patients awaiting programming can be simultaneously identified, and programming a single patient only requires switching within the patient list. Data from multiple groups can also be stored. In addition, the technology offers remote follow-up capabilities. It is therefore convenient, time-saving, and economical for patients. To address the outlined issues, we developed the SceneRay wireless and remote DBS system. This system has significant advantages across all three stages of programming compared to conventional programming methods. Patient convenience is markedly improved, while risk of infection and total treatment time are minimized, thereby leading to an overall benefit for doctors and patients alike.

Wireless closed-loop deep brain stimulation using microelectrode array probes

Closed loop deep brain stimulation: an evolving technology

Technology of deep brain stimulation: current status and future directions

Standardized wireless deep brain stimulation system for mice

A Novel Closed-Loop Electrical Brain Stimulation Device Featuring Wireless Low-Energy Ultrasound Power and Communication

Deep Brain Stimulation Initiative: Toward Innovative Technology, New Disease Indications, And Approaches To Current And Future Clinical Challenges In Neuromodulation Therapy

Advances in Understanding The Mechanisms of Deep Brain Stimulation

Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders

Wireless-Powering Deep Brain Stimulation Platform Based on 1D-Structured Magnetoelectric Nanochains Applied in Antiepilepsy Treatment

Review of Noninvasive or Minimally Invasive Deep Brain Stimulation

A Remote and Wireless Deep Brain Stimulation Programming System

Uncovering the Mechanism(S) of Deep Brain Stimulation

New Frontiers for Deep Brain Stimulation: Directionality, Sensing Technologies, Remote Programming, Robotic Stereotactic Assistance, Asleep Procedures, and Connectomics

Closed-Loop Adaptive Deep Brain Stimulation in Parkinson’s Disease: Procedures to Achieve It and Future Perspectives

Advances in The Development of New Stimulation Paradigms of Deep Brain Stimulation

The mechanisms of action of deep brain stimulation and ideas for the future development

Closed Loop Deep Brain Stimulation for PTSD, Addiction, and Disorders of Affective Facial Interpretation: Review and Discussion of Potential Biomarkers and Stimulation Paradigms

Probing responses to deep brain stimulation with functional magnetic resonance imaging

Microscale multicircuit brain stimulation: Achieving real-time brain state control for novel applications

[Networkmodulation through deep brain stimulation]

On closed-loop brain stimulation systems for improving the quality of life of patients with neurological disorders